In breast cancer, the MEK/ERK/c-Jun/ABCA1 pathway was activated, leading to cholesterol efflux and membrane fluidity enhancement, thereby promoting the epithelial-mesenchymal transition of cancer cells28. Here, JUN is linked to cancer.